Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMID 2867114)

Published in J Immunol on February 01, 1986

Authors

D K Blanchard, J Y Djeu, T W Klein, H Friedman, W E Stewart

Articles citing this

Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun (1989) 2.13

A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun (1995) 1.99

Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect Immun (1994) 1.71

Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun (1996) 1.57

Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect Immun (1993) 1.56

Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma. J Exp Med (1993) 1.43

Release of cytokines induced by Salmonella typhimurium porins. Infect Immun (1993) 1.41

Endotoxemia and human liver transplantation. Transplant Proc (1989) 1.28

Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect Immun (1992) 1.20

Purification of a factor which provides a costimulatory signal for gamma interferon production. Infect Immun (1993) 1.14

Role of gamma interferon in induction of natural killer activity by Legionella pneumophila in vitro and in an experimental murine infection model. Infect Immun (1988) 1.12

Gamma interferon production in endotoxin-responder and -nonresponder mice during infection. Infect Immun (1991) 1.11

Cyclic ADP-ribose is a second messenger in the lipopolysaccharide-stimulated proliferation of human peripheral blood mononuclear cells. Biochem J (2003) 1.06

Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Infect Immun (2001) 1.03

Induction of murine gamma interferon production by lipopolysaccharide and interleukin-2 in Propionibacterium acnes-induced peritoneal exudate cells. Infect Immun (1987) 0.97

Effect of cytokines on liver necrosis. World J Gastroenterol (1998) 0.95

Roles of interferon produced in physiological conditions. A speculative review. Immunology (1988) 0.91

Haemophilus influenzae porin contributes to signaling of the inflammatory cascade in rat brain. Infect Immun (2001) 0.89

Upregulation and induction of surface antigens with special reference to MHC class II expression in microglia in postnatal rat brain following intravenous or intraperitoneal injections of lipopolysaccharide. J Anat (1994) 0.88

CD34(+) hematopoietic stem cells exert accessory function in lipopolysaccharide-induced T cell stimulation and CD80 expression on monocytes. J Exp Med (1999) 0.85

A novel method to identify and characterise peptide mimotopes of heat shock protein 70-associated antigens. J Immune Based Ther Vaccines (2006) 0.84

Brucella abortus regulates bovine macrophage-T-cell interaction by major histocompatibility complex class II and interleukin-1 expression. Infect Immun (1989) 0.83

The generation of macrophages with anti-inflammatory activity in the absence of STAT6 signaling. J Leukoc Biol (2015) 0.81

Porins and lipopolysaccharide induce apoptosis in human spermatozoa. Clin Diagn Lab Immunol (2001) 0.80

Loci controlling lymphocyte production of interferon c after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility. Cancer Immunol Immunother (2010) 0.78

Quercetin and Bornyl Acetate Regulate T-Lymphocyte Subsets and INF-γ/IL-4 Ratio In Utero in Pregnant Mice. Evid Based Complement Alternat Med (2010) 0.78

Differential effect of alpha-interferon and gamma-interferon on thromboplastin response in monocytes and endothelial cells. Clin Exp Immunol (1987) 0.77

Effect of a Novel Ashwagandha-based Herbomineral Formulation on Pro-inflammatory Cytokines Expression in Mouse Splenocyte Cells: A Potential Immunomodulator. Pharmacogn Mag (2017) 0.77

Modulation of macrophage Ia expression by lipopolysaccharide: stem cell requirements, accessory lymphocyte involvement, and IA-inducing factor production. Infect Immun (1989) 0.75

Growth inhibition of tumour cells by a liposome-encapsulated, mycolic acid-containing glycolipid, trehalose 2,3,6'-trimycolate. Immunology (1991) 0.75

Anomaly Detection in Host Signaling Pathways for the Early Prognosis of Acute Infection. PLoS One (2016) 0.75

Macrophage phenotype in response to ECM bioscaffolds. Semin Immunol (2017) 0.75

Articles by these authors

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer (2000) 4.96

An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol (1992) 4.85

Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types. J Exp Med (1989) 3.22

Priming: a nonantiviral function of interferon. J Virol (1971) 2.95

A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet (1990) 2.89

Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol (1979) 2.80

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. J Exp Med (1983) 2.67

Cancer patients' perceptions of their disease and its treatment. Br J Cancer (1988) 2.66

Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells. Int J Cancer (1977) 2.39

Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol (1986) 2.37

Growth of Legionella pneumophila in thioglycolate-elicited peritoneal macrophages from A/J mice. Infect Immun (1988) 2.37

Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat Immunol (2000) 2.35

Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A (1985) 2.33

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest (1983) 2.32

The importance of measuring cotinine levels to identify smokers in clinical trials. Clin Pharmacol Ther (1994) 2.11

A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer. Oncogene (2000) 2.07

Relative sensitivities of viruses to different species of interferon. J Virol (1969) 2.02

Direct localization and visualization of hyaluronate lyase activity by agar gel electrophoresis. Proc Soc Exp Biol Med (1967) 2.00

There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys (1999) 1.96

Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992-1995. Arch Pediatr Adolesc Med (2000) 1.95

Target cell specificity of two species of human interferon-alpha produced in Escherichia coli and of hybrid molecules derived from them. Proc Natl Acad Sci U S A (1981) 1.89

Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. J Immunol (1983) 1.84

Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses. J Exp Med (1982) 1.81

Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol (1999) 1.80

Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J Immunol (1990) 1.78

Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin. Proc Soc Exp Biol Med (1974) 1.76

Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol (2001) 1.74

Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J Leukoc Biol (1988) 1.73

Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol (1988) 1.70

Differences in HLA class II alleles of isolated South American Indian populations from Brazil and Argentina. Hum Immunol (1993) 1.69

Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65

Effects of RES "blockade" on antibody-formation. I. Suppressed cellular and humoral haemolysin responses in mice injected with carbon particles. Immunology (1969) 1.61

Radiometric detection of bacteremia: requirement for terminal subcultures. J Clin Microbiol (1977) 1.61

Bacterial heat shock proteins directly induce cytokine mRNA and interleukin-1 secretion in macrophage cultures. Infect Immun (1994) 1.54

High serum and ascitic soluble interleukin-2 receptor alpha levels in advanced epithelial ovarian cancer. Blood (1993) 1.54

Release of tumor necrosis factor by human polymorphonuclear leukocytes. Blood (1990) 1.50

Role of macrophages in the augementation of mouse natural killer cell activity by poly I:C and interferon. J Immunol (1979) 1.49

Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: identification of perforin and granzyme B mobilization by functional ERK2. J Exp Med (1998) 1.48

Cryptococcal capsular polysaccharide-induced modulation of murine immune responses. Infect Immun (1982) 1.47

Involvement of mannose receptor in cytokine interleukin-1beta (IL-1beta), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1beta (MIP-1beta), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages. Infect Immun (1997) 1.47

Fatigue in Parkinson's disease. Neurology (1993) 1.46

Tumors of the esophagus. World J Surg (2000) 1.44

Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med (1985) 1.43

Identification of the cell multiplication inhibitory factors in interferon preparations as interferons. Nature (1976) 1.41

Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells. Oncogene (2006) 1.40

Immune-type receptor genes in zebrafish share genetic and functional properties with genes encoded by the mammalian leukocyte receptor cluster. Proc Natl Acad Sci U S A (2001) 1.40

Legionella pneumophila-induced blastogenesis of murine lymphoid cells in vitro. Infect Immun (1984) 1.39

Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol (1984) 1.38

Building collaborative relationships with families of the mentally ill. Hosp Community Psychiatry (1988) 1.38

Variability of X-ray emission from M87. Nature (1971) 1.38

Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. J Biol Chem (1992) 1.35

Vibrio vulnificus resists phagocytosis in the absence of serum opsonins. Infect Immun (1985) 1.35

IL-2 independent growth and cytotoxicity of herpesvirus saimiri-infected human CD8 cells and involvement of two open reading frame sequences of the virus. Virology (1993) 1.35

Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils. J Immunol (2001) 1.32

Temperature control of initiation of protein synthesis in Escherichia coli. J Mol Biol (1971) 1.32

Immunosuppressive effects of Friend and Rauscher leukemia disease viruses on cellular and humoral antibody formation. J Natl Cancer Inst (1968) 1.31

Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J Immunol (1989) 1.30

Production, partial purification and characterization of human and murine interferons--type II. Mol Immunol (1980) 1.29

Outcomes of extremely low birth weight infants. Pediatrics (1996) 1.28

Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. J Immunol (2000) 1.28

Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav Immun (1995) 1.28

Distinct molecular species of interferons. Virology (1974) 1.27

The cannabinoid system and cytokine network. Proc Soc Exp Biol Med (2000) 1.27

Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). Infect Immun (1994) 1.27

Viral hepatitis, type A. Identification by specific complement fixation and immune adherence tests. N Engl J Med (1975) 1.25

Tumors of the rectum and anal canal. World J Surg (2000) 1.24

Population study of triazolam pharmacokinetics. Br J Clin Pharmacol (1986) 1.24

An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens (1997) 1.24

Immunosuppression by leukemia viruses. I. Effect of Friend disease virus on cellular and humoral hemolysin responses of mice to a primary immunization with sheep erythrocytes. J Immunol (1968) 1.23

Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo. J Exp Med (1980) 1.23

Molecular heterogeneity of human leukocyte interferon: two populations differing in molecular weights, requirements for renaturation, and cross-species antiviral activity. Virology (1975) 1.23

Morphology and lytic mechanisms of interleukin 3-dependent natural cytotoxic cells: tumor necrosis factor as a possible mediator. J Immunol (1986) 1.23

A simple hydrogenase-linked assay for ferredoxin and flavodoxin. Anal Biochem (1979) 1.22

Differential growth of Legionella pneumophila in guinea pig versus mouse macrophage cultures. Infect Immun (1987) 1.21

Marijuana, immunity and infection. J Neuroimmunol (1998) 1.21

Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect Immun (1994) 1.21

Chronic neutropenia mediated by fas ligand. Blood (2000) 1.20

Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species. Infect Immun (1983) 1.20

Variation in antigenic determinants of p53 transformation-related protein obtained from various species. J Immunol (1983) 1.19

Human large granular lymphocytes are potent producers of interleukin-1. Nature (1984) 1.18

Dorsal column stimulation for control of pain. Preliminary report on 30 patients. J Neurosurg (1972) 1.18

Cannabinoid receptors and immunity. Immunol Today (1998) 1.17

Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity. J Leukoc Biol (1989) 1.17